OBJECTIVES: Malnutrition is prevalent among cancer patients, and maybe correlated with altered quality of life. The objective of this study is to determine wether quality of life among cancer patients on chemotherapy at the National Kidney and Transplant Institute- Cancer Unit differs from patients with normal nutrition based on the Subjective Global Assessment scale. METHODS: A cross sectional study was conducted among cancer patients admitted for chemotherapy at the National Kidney and Transplant Institute-Cancer Unit from January to May 2011. Demographic profile, performance status by Eastern Cooperative Oncology Group performance scale, nutritional status assessment by Subjective Global Assessment, and quality of life assessment by the European Organization for Research and Treatment of Cancer QoL-30 core module were obtained. Descriptive statistics and ANOVA were performed for analysis of quality of life parameters and nutritional status. RESULTS: A total of 97 subjects were included in this study, 66 subjects (68.04%) were females and 31 (31.96%) were males. Mean age was 54.55 ± 11.14 years, while mean performance status by the Eastern Cooperative Oncology Group classification was 0.88 ± 0.83 with a range of 0-3. According to the Subjective Global Assessment, there were 58 patients with SGA A, classified to have adequate nutrition, and 39 patients (40.21%) were considered malnourished. Among these 39 patients, 32 were classified SGA-B (moderately malnourished) and 7 were classified SGA C (severely malnourished) mean global quality of life was 68.73 ± 19.05. Results from ANOVA test revealed that patients were statistically different across the Subjective Global Assessment groups according to global quality of life (p<0.001), physical (p<0.001), role (p<0.001), emotional (p<0.001), and cognitive functioning (p<0.001); fatigue (p<0.001), nausea and vomiting (p<0.001), pain (p<0.001), insomnia (p<0.001), and appetite loss (p<0.001). CONCLUSION: GLOBAL QUALITY OF LIFE AND ITS PARAMETERS: physical state, role, emotional state, cognitive functioning, cancer fatigue, nausea and vomiting, pain, insomnia, and loss of appetite were statistically different across all Subjective Global Assessment groups. Moreover, there was no difference between financial difficulties, social functioning, constipation and diarrhea among the Subjective Global Assessment groups.
OBJECTIVES: Malnutrition is prevalent among cancerpatients, and maybe correlated with altered quality of life. The objective of this study is to determine wether quality of life among cancerpatients on chemotherapy at the National Kidney and Transplant Institute- Cancer Unit differs from patients with normal nutrition based on the Subjective Global Assessment scale. METHODS: A cross sectional study was conducted among cancerpatients admitted for chemotherapy at the National Kidney and Transplant Institute-Cancer Unit from January to May 2011. Demographic profile, performance status by Eastern Cooperative Oncology Group performance scale, nutritional status assessment by Subjective Global Assessment, and quality of life assessment by the European Organization for Research and Treatment of Cancer QoL-30 core module were obtained. Descriptive statistics and ANOVA were performed for analysis of quality of life parameters and nutritional status. RESULTS: A total of 97 subjects were included in this study, 66 subjects (68.04%) were females and 31 (31.96%) were males. Mean age was 54.55 ± 11.14 years, while mean performance status by the Eastern Cooperative Oncology Group classification was 0.88 ± 0.83 with a range of 0-3. According to the Subjective Global Assessment, there were 58 patients with SGA A, classified to have adequate nutrition, and 39 patients (40.21%) were considered malnourished. Among these 39 patients, 32 were classified SGA-B (moderately malnourished) and 7 were classified SGA C (severely malnourished) mean global quality of life was 68.73 ± 19.05. Results from ANOVA test revealed that patients were statistically different across the Subjective Global Assessment groups according to global quality of life (p<0.001), physical (p<0.001), role (p<0.001), emotional (p<0.001), and cognitive functioning (p<0.001); fatigue (p<0.001), nausea and vomiting (p<0.001), pain (p<0.001), insomnia (p<0.001), and appetite loss (p<0.001). CONCLUSION: GLOBAL QUALITY OF LIFE AND ITS PARAMETERS: physical state, role, emotional state, cognitive functioning, cancer fatigue, nausea and vomiting, pain, insomnia, and loss of appetite were statistically different across all Subjective Global Assessment groups. Moreover, there was no difference between financial difficulties, social functioning, constipation and diarrhea among the Subjective Global Assessment groups.
Entities:
Keywords:
Cancer nutrition; Quality of life; Subjective global assessment
Authors: A S Detsky; J R McLaughlin; J P Baker; N Johnston; S Whittaker; R A Mendelson; K N Jeejeebhoy Journal: JPEN J Parenter Enteral Nutr Date: 1987 Jan-Feb Impact factor: 4.016
Authors: Digant Gupta; Christopher G Lis; Joel Granick; James F Grutsch; Pankaj G Vashi; Carolyn A Lammersfeld Journal: J Clin Epidemiol Date: 2006-04-19 Impact factor: 6.437
Authors: N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes Journal: J Natl Cancer Inst Date: 1993-03-03 Impact factor: 13.506
Authors: M M Marín Caro; C Gómez Candela; R Castillo Rabaneda; T Lourenço Nogueira; M García Huerta; V Loria Kohen; M Villarino Sanz; P Zamora Auñón; L Luengo Pérez; P Robledo Sáenz; C López-Portabella; A Zarazaga Monzón; J Espinosa Rojas; Raquel Nogués Boqueras; L Rodríguez Suárez; S Celaya Pérez; J Pardo Masferrer Journal: Nutr Hosp Date: 2008 Sep-Oct Impact factor: 1.057
Authors: S Schwarz; O Prokopchuk; K Esefeld; S Gröschel; J Bachmann; S Lorenzen; H Friess; M Halle; M E Martignoni Journal: BMC Cancer Date: 2017-02-14 Impact factor: 4.430
Authors: Linh Thuy Nguyen; Anh Kim Dang; Phuong Thi Duong; Hanh Bich Thi Phan; Chinh Tuyet Thi Pham; Anh Tuan Le Nguyen; Huong Thi Le Journal: Cancer Med Date: 2021-02-07 Impact factor: 4.452
Authors: Soo Liang Ooi; Sok Cheon Pak; Peter S Micalos; Emily Schupfer; Rob Zielinski; Thomas Jeffries; Garth Harris; Terry Golombick; David McKinnon Journal: Contemp Clin Trials Commun Date: 2020-05-29